Related Experiment Video
Updated: Jan 13, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Enhancing Local Functional Structure Features to Improve Drug-Target Interaction Prediction
Baoming Feng1, Haofan Du2, Henry H Y Tong1
1Center for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999708, China.
None:
Molecular simulation is central to modern drug discovery but is often limited by high computational cost and the complexity of molecular interactions. Deep-learning drug-target interaction (DTI) prediction can accelerate screening; however, many models underuse the local functional structure features-binding motifs, reactive groups, and residue-level fragments-that drive recognition. We present LoF-DTI, a framework that explicitly represents and couples such local features. Drugs are converted from SMILES into molecular graphs and targets from sequences into feature representations. On the drug side, a Jumping Knowledge (JK) enhanced Graph Isomorphism Network (GIN) extracts atom- and neighborhood-level patterns; on the target side, residual CNN blocks with progressively enlarged receptive fields, augmented by N-mer substructural statistics, capture multi-scale local motifs. A Gated Cross-Attention (GCA) module then performs atom-to-residue interaction learning, highlighting decisive local pairs and providing token-level interpretability through attention scores. By prioritizing locality during both encoding and interaction, LoF-DTI delivers competitive results across multiple benchmarks and improves early retrieval relevant to virtual screening. Case analyses show that the model recovers known functional binding sites, suggesting strong potential to provide mechanism-aware guidance for molecular simulation and to streamline the drug design pipeline.
More Related Videos
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Discovery: Overview
Protein-protein Interfaces
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites